Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label in an attempt to suppress behavioral estrus. However, a controlled research study found that MPA was not effective at suppression of behavioral estrus. (1) Many veterinarians believe MPA modifies behavior by producing a calming effect in the horse and does not have a therapeutic benefit that goes beyond this behavior modification. Therefore, the AAEP recommends that MPA should not be administered to horses in competition.
1. Gee EK, C DeLuca, JL Stylski, PM McCue. Efficacy of medroxyprogesterone acetate in suppression of estrus in cycling mares. J Equine Vet Sci 2009;29:140-145.
Approved by the AAEP board of directors in 2019.
Related Resources
Infectious Neurologic Disease Field Diagnostic Guidelines
The AAEP Field Diagnostic Guidelines provide step-by-step instruction for the diagnostic work-up…
Neurologic Disease Differential and Diagnostic Flow Chart
This flowchart contains differential diagnoses for acute infectious neurologic disease in adult…
Position on Private Practice by Regulatory Veterinarians
The AAEP views as a conflict of interest the participation in private…